Powered by

Advertisment
Home Shark Tank India

NeuraSim on Shark Tank India: Virtual Reality Technology

NeuraSim founders Dr. Ramesh S Ve and Mr. Maciej Kossowski appeared on Shark Tank India season 4 in episode 28 for seeking an offer of ₹ 1 Cr. for 8% equity at the valuation of ₹ 12.5 Cr. How does this deal close here?

By Saroj Kumawat
New Update
Shark tank website (21)

NeuraSim appeared in Shark Tank India Season-4  in Episode 28. Karnataka-based NeuraSim is virtual reality technology in healthcare treatment. Its product, Bee VeeTM, is a CE-certified immersive virtual reality therapy that offers effective treatment options for amblyopia (lazy eye), squint eyes, headaches, and eye movement disorders. Its specialities are healthcare, VR, amblyopia therapy, vision therapy, Dichoptic therapy, neuroscience, Eye movement, and Stereopsis + Fusional Training.

   Dr. Ramesh S Ve and Mr. Maciej Kossowski are the founders of NeuraSim. Their dedication to quality, creativity, and customer satisfaction is at the heart of NeuraSim's success. At Shark Tank India, they were seeking an offer of  ₹1 Cr. for 8% equity at the valuation of ₹12.5 Cr. 

 Also read- Profitable Future Business Ideas in India for 2025, 2030, 2050.

NeuraSim Valuation, Funding, and Company Profile

Company 

NeuraSim 

Valuation 

INR 12.5 Cr.

Founder

 Dr. Ramesh S Ve and Mr. Maciej Kossowski 

Headquarters 

Bengaluru South, Karnataka 

Founding Year 

2023

Industry Public Health

Profitability 

Undisclosed 

Got Investment 

No

Conclusion - NeuraSim Shark Tank India

It was an engaging episode at Shark Tank India - Season 4 with all sharks: Namita Thapar, Aman GuptaPeyush Bansal, Anupam Mittal and Vineeta Singh where they didn't secure a deal but received valuable mentorship to help grow their business NeuraSim. Now, everyone is eagerly awaiting the next episode, looking forward to discovering more intriguing businesses and their strategies for raising funds from the panel of judges. 

Also read-  Best Business Ideas Under 5 Lakhs in India for 2025.